5569404477 · Partihandel med andra livsmedel · STOCKHOLM
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Soflin Pharma AB lifted its operating margin from 20.3 % to 30 % in 2024. The company’s operating margin of 30 % exceeded three quarters of the 351 comparable companies in its industry. The net result has been positive in three consecutive comparable periods, from 2022 to 2024. The company’s 2 employees corresponded to net sales of roughly 5.5 MSEK per employee in 2024.
Calculated by ArkivNord from filed annual reports. About the methodology
Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge.
Net revenue
11 MSEK
▲ +14%Net result
2 MSEK
▲ +33%Employees
2
Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
arkivnord